Data search


search
Exact
Search

Results for MligTC455_16943

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_16943 3243 67.57 Mlig455_015939, Mlig455_059704

Neo: -

Age: logFC(26M/2M)=-0.433

Region-enriched R7: 1.287/0.00682
Region-enriched R6: 1.072/0.03826

Regeneration-downregulated BL: -2.106

Regeneration-depleted BL: -2.106

Mlig455_015939 {REF} {Length: 1575} {RNA1509_17366} {RNA1310_24251} {RNA815_10435}

Mlig455_059704 {REF} {Length: 2179} {RNA1509_17366} {RNA1310_24251, RNA1509_17366} {RNA1509_17366, RNA815_10435}

Cumulative graph for MligTC455_16943

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 -1.715 6.233 0.04474 0.50802
RegionR2 -0.2 6.233 0.62021 0.96458
RegionR3 0.395 6.233 0.23356 0.77562
RegionR4 -0.065 6.233 0.88168 1.00000
RegionR5 -0.868 6.233 0.01886 0.09290
RegionR6 1.072 6.233 0.00099 0.03826
RegionR7 1.287 6.233 0.00012 0.00682
RegionR8 0.092 6.233 0.83979 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 0.734 6.233 0.49863 1.00000
RegenerationR2 -0.169 6.233 0.66687 0.94426
RegenerationR3 0.404 6.233 0.32523 0.75256
RegenerationR4 0.238 6.233 0.57989 0.90548
RegenerationR5 0.269 6.233 0.52048 0.86999
RegenerationR6 -0.494 6.233 0.22438 0.56949
RegenerationBL -2.106 6.233 0.00000 0.00029 Specific for BL: -2.106
RegenerationTP 1.07 6.233 0.00652 0.13625


Genes with expression patterns similar to MligTC455_16943

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_16943 3243 67.57 Mlig455_015939, Mlig455_059704

Neo: -

Age: logFC(26M/2M)=-0.433

Region-enriched R7: 1.287/0.00682
Region-enriched R6: 1.072/0.03826

Regeneration-downregulated BL: -2.106

Regeneration-depleted BL: -2.106

6 1.000 1.000 1.000 1.000 1.000 1.000

Mlig455_015939 {REF} {Length: 1575} {RNA1509_17366} {RNA1310_24251} {RNA815_10435}

Mlig455_059704 {REF} {Length: 2179} {RNA1509_17366} {RNA1310_24251, RNA1509_17366} {RNA1509_17366, RNA815_10435}
2. MligTC455_45463 30091 626.89 Mlig455_024175, Mlig455_024193

Neo: -

Age: Down-Down-Up, logFC(26M/2M)=-0.171

2.582 - - 0.783 - 0.968 0.831

Mlig455_024175 {REF} {Length: 641} {TRANSSPLICED} {Pfam: UPF0506 [PF11703.10, score=39.8]; PhTx neurotoxin family [PF08116.13, score=20.9]; Dickkopf N-terminal cysteine-rich region [PF04706.14, score=19.1]} {RNA1509_3088} {RNA1310_51767.2} {RNA815_11592}

Mlig455_024193 {REF} {Length: 671} {TRANSSPLICED} {Pfam: UPF0506 [PF11703.10, score=39.8]; PhTx neurotoxin family [PF08116.13, score=20.9]; Dickkopf N-terminal cysteine-rich region [PF04706.14, score=19.1]} {RNA1509_17618, RNA1509_2352, RNA1509_2885, RNA1509_3088, RNA1509_34299} {RNA1310_51767.2, RNA1509_17618, RNA1509_2352, RNA1509_2885, RNA1509_3088, RNA1509_34299} {RNA1509_17618, RNA1509_2352, RNA1509_2885, RNA1509_3088, RNA1509_34299, RNA815_11592}
3. MligTC455_30046 464 9.68 Mlig455_000635

Neo: -

Age: -

Region-enriched R7: 3.850/0.00000

LTBP2 1.894 - - - 0.951 - 0.943 Mlig455_000635 {REF} {Length: 6232} {Pfam: Calcium-binding EGF domain [PF07645.17, score=81.0]; Complement Clr-like EGF-like [PF12662.9, score=35.4]; EGF-like domain [PF00008.29, score=19.4]; EGF domain [PF12947.9, score=18.7]} {Human: ENSG00000119681, LTBP2, latent transforming growth factor beta binding protein 2, [Score=130, Expect=2e-29]} {Mouse: ENSMUSG00000002020, Ltbp2, latent transforming growth factor beta binding protein 2, [Score=124, Expect=9e-28]} {Dmel: FBgn0035798, frac, faulty attraction, [Score=99.8, Expect=2e-20]} {Celegans: WBGene00003497, mup-4, Transmembrane matrix receptor MUP-4, [Score=98.6, Expect=3e-20]} {Smed: dd_Smed_v6_2649_0_1, dd_Smed_v6_2649_0_1, [Score=107, Expect=6e-23]} {RNA1509_5079} {RNA1310_710} {RNA815_417}
4. MligTC455_03803 364 7.58 Mlig455_053227, Mlig455_065046

Neo: -

Age: Up-Down-Down

Region-enriched R7: 3.052/0.00004

Regeneration-downregulated BL: -3.099

Regeneration-depleted BL: -3.099

CRACR2A 1.884 - - - 0.976 - 0.908

Mlig455_053227 {REF} {Length: 1663} {Pfam: EF-hand domain pair [PF13499.8, score=35.4]; EF-hand domain [PF13405.8, score=31.1]; EF hand [PF00036.34, score=30.6]; EF-hand domain pair [PF13833.8, score=30.3]} {Human: ENSG00000130038, CRACR2A, calcium release activated channel regulator 2A, [Score=142, Expect=1e-38]} {Mouse: ENSMUSG00000061414, Cracr2a, calcium release activated channel regulator 2A, [Score=142, Expect=3e-37]} {Smed: dd_Smed_v6_2966_0_1, dd_Smed_v6_2966_0_1, [Score=168, Expect=5e-47]} {RNA1509_20561} {RNA1310_2186} {RNA815_7541}

Mlig455_065046 {REF} {Length: 5354} {TRANSSPLICED} {Pfam: Ras family [PF00071.24, score=173.2]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=108.0]; ADP-ribosylation factor family [PF00025.23, score=64.9]; 50S ribosome-binding GTPase [PF01926.25, score=35.5]; EF-hand domain pair [PF13499.8, score=33.8]; Gtr1/RagA G protein conserved region [PF04670.14, score=30.6]; EF-hand domain [PF13405.8, score=29.1]; EF hand [PF00036.34, score=28.4]; EF-hand domain pair [PF13833.8, score=27.8]; Elongation factor Tu GTP binding domain [PF00009.29, score=21.7]} {Human: ENSG00000130038, CRACR2A, calcium release activated channel regulator 2A, [RH, Score=190, Expect=2e-50]} {Mouse: ENSMUSG00000061414, Cracr2a, calcium release activated channel regulator 2A, [RH, Score=186, Expect=3e-49]} {Dmel: FBgn0051118, RabX4, [Score=156, Expect=2e-43]} {Celegans: WBGene00007067, 4R79.2, Rab-44, [RH, Score=204, Expect=2e-58]} {Smed: dd_Smed_v6_2966_0_1, dd_Smed_v6_2966_0_1, [RH, Score=260, Expect=2e-76]} {RNA1509_20561} {RNA1310_2186, RNA1509_20561} {RNA1509_20561, RNA815_7541}
5. MligTC455_46599 1220 25.42 Mlig455_013377

Neo: -

Age: -

Region-enriched R7: 4.322/0.00000
Region-enriched R6: 3.519/0.00002

Regeneration-downregulated BL: -3.731

Regeneration-depleted BL: -3.731

CALB2 1.784 - - - 0.980 - 0.804 Mlig455_013377 {REF} {Length: 4778} {Pfam: EF hand [PF00036.34, score=120.9]; EF-hand domain [PF13405.8, score=114.5]; EF-hand domain pair [PF13499.8, score=88.6]; EF hand [PF13202.8, score=82.4]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=33.8]; EF-hand domain pair [PF13833.8, score=32.5]} {Human: ENSG00000172137, CALB2, calbindin 2, [RH, Score=219, Expect=7e-70]; ENSG00000282830, CALB2, calbindin 2, [RH, Score=219, Expect=7e-70]} {Mouse: ENSMUSG00000003657, Calb2, calbindin 2, [RH, Score=218, Expect=1e-69]} {Dmel: FBgn0004580, Cbp53E, Calbindin 53E, [RH, Score=360, Expect=4e-125]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=50.8, Expect=1e-07]} {Smed: dd_Smed_v6_1230_0_1, dd_Smed_v6_1230_0_1, [RH, Score=422, Expect=3e-150]} {RNA1509_11338} {RNA1310_24068, RNA1509_11338} {RNA1509_11338, RNA815_10142}
6. MligTC455_47911 454 9.45 Mlig455_025174, Mlig455_025185, Mlig455_063945

Neo: -

Age: Down-Down-Up

Region-enriched R7: 1.848/0.00637

INAFM2 1.783 - - - 0.962 - 0.821

Mlig455_025174 {REF} {Length: 1166} {Pfam: TRP-interacting helix [PF15018.8, score=59.1]; Voltage-dependent anion channel [PF03595.19, score=21.3]} {Human: ENSG00000259330, INAFM2, InaF motif containing 2, [RH, Score=72.4, Expect=4e-17]} {Mouse: ENSMUSG00000074918, Inafm2, InaF motif containing 2, [RH, Score=72.0, Expect=4e-17]} {Dmel: FBgn0260812, inaF-D, [RH, Score=51.6, Expect=6e-09]} {Celegans: WBGene00009325, F32D8.15, [RH, Score=48.5, Expect=2e-08]} {Smed: dd_Smed_v6_11468_0_1, dd_Smed_v6_11468_0_1, [RH, Score=66.6, Expect=6e-16]} {RNA1509_26679} {RNA1310_3928} {RNA815_30540}

Mlig455_025185 {REF} {Length: 1331} {Pfam: TRP-interacting helix [PF15018.8, score=59.1]; Voltage-dependent anion channel [PF03595.19, score=21.3]} {Human: ENSG00000259330, INAFM2, InaF motif containing 2, [RH, Score=72.4, Expect=4e-17]} {Mouse: ENSMUSG00000074918, Inafm2, InaF motif containing 2, [RH, Score=72.0, Expect=4e-17]} {Dmel: FBgn0260812, inaF-D, [RH, Score=51.6, Expect=6e-09]} {Celegans: WBGene00009325, F32D8.15, [RH, Score=48.5, Expect=2e-08]} {Smed: dd_Smed_v6_11468_0_1, dd_Smed_v6_11468_0_1, [RH, Score=66.6, Expect=6e-16]} {RNA1509_26679} {RNA1310_3928, RNA1509_26679} {RNA1509_26679, RNA815_30540}

Mlig455_063945 {REF} {Length: 1146} {Pfam: TRP-interacting helix [PF15018.8, score=59.1]; Voltage-dependent anion channel [PF03595.19, score=21.3]} {Human: ENSG00000259330, INAFM2, InaF motif containing 2, [RH, Score=72.4, Expect=4e-17]} {Mouse: ENSMUSG00000074918, Inafm2, InaF motif containing 2, [RH, Score=72.0, Expect=4e-17]} {Dmel: FBgn0260812, inaF-D, [RH, Score=51.6, Expect=6e-09]} {Celegans: WBGene00009325, F32D8.15, [RH, Score=48.5, Expect=2e-08]} {Smed: dd_Smed_v6_11468_0_1, dd_Smed_v6_11468_0_1, [RH, Score=66.6, Expect=6e-16]} {RNA1509_26679, RNA1509_58648} {RNA1310_3928, RNA1509_58648} {RNA1509_58648, RNA815_30540}
7. MligTC455_27270 533 11.1 Mlig455_009365

Neo: -

Age: -

1.774 - - - 0.951 - 0.823 Mlig455_009365 {REF} {Length: 4198} {RNA1509_2150} {RNA1310_25787.1} {RNA815_1043.1}
8. MligTC455_20277 1402 29.21 Mlig455_006574

Neo: -

Age: -

Region-enriched R7: 2.254/0.00000
Region-enriched R8: 2.021/0.00003
Region-enriched R2: 1.418/0.02203

SH3GLB1 1.76 - - - - 0.806 0.954 Mlig455_006574 {REF} {Length: 2129} {Pfam: BAR domain [PF03114.20, score=173.9]; Bin/amphiphysin/Rvs domain for vesicular trafficking [PF10455.11, score=30.4]; BAR domain of APPL family [PF16746.7, score=18.4]} {Human: ENSG00000097033, SH3GLB1, SH3 domain containing GRB2 like, endophilin B1, [Score=216, Expect=3e-68]} {Mouse: ENSMUSG00000037062, Sh3glb1, SH3-domain GRB2-like B1 (endophilin), [Score=217, Expect=5e-69]} {Dmel: FBgn0034433, EndoB, Endophilin B, [Score=198, Expect=1e-61]} {Celegans: WBGene00001335, F35A5.8, Endophilin-Related Protein, [Score=183, Expect=4e-56]} {Smed: dd_Smed_v6_1387_0_2, dd_Smed_v6_1387_0_2, [Score=170, Expect=2e-52]} {RNA1509_12063} {RNA1310_16136.1} {RNA815_6397.1}
9. MligTC455_37358 147 3.06 Mlig455_036287, Mlig455_062056

Neo: -

Age: -

1.705 - - - 0.954 - 0.751

Mlig455_036287 {REF} {Length: 5254} {RNA1509_10387} {RNA1310_6525.1} {RNA815_3756.1}

Mlig455_062056 {REF} {Length: 720} {Pfam: Histone H1-like nucleoprotein HC2 [PF07382.13, score=22.8]} {RNA1509_25482} {RNA1310_25290} {RNA815_64127}
10. MligTC455_48428 578 12.04 Mlig455_034987, Mlig455_053697, Mlig455_064889

Neo: -

Age: -

NEO1 1.698 - - 0.746 - - 0.952

Mlig455_034987 {REF} {Length: 1449} {Pfam: Immunoglobulin domain [PF13927.8, score=83.0]; Immunoglobulin I-set domain [PF07679.18, score=69.9]; Immunoglobulin domain [PF13895.8, score=59.6]; Immunoglobulin domain [PF00047.27, score=52.1]; Immunoglobulin V-set domain [PF07686.19, score=43.6]; Immunoglobulin domain [PF18452.3, score=26.9]} {Human: ENSG00000067141, NEO1, neogenin 1, [Score=102, Expect=1e-22]; ENSG00000166450, PRTG, protogenin, [Score=97.8, Expect=3e-21]} {Mouse: ENSMUSG00000036030, Prtg, protogenin, [Score=94.4, Expect=3e-20]} {Dmel: FBgn0011592, fra, frazzled, [Score=76.6, Expect=1e-14]} {Celegans: WBGene00004256, pxn-1, Peroxidasin homolog, [Score=51.6, Expect=9e-07]} {Smed: dd_Smed_v6_11123_0_1, dd_Smed_v6_11123_0_1, [Score=59.7, Expect=2e-09]} {RNA1509_18708} {RNA1310_41845} {RNA815_22774}

Mlig455_053697 {REF} {Length: 5168} {Pfam: Fibronectin type III domain [PF00041.23, score=164.7]; Immunoglobulin domain [PF13927.8, score=111.6]; Immunoglobulin I-set domain [PF07679.18, score=105.0]; Immunoglobulin domain [PF13895.8, score=85.3]; Immunoglobulin domain [PF00047.27, score=61.8]; Immunoglobulin V-set domain [PF07686.19, score=50.1]; Purple acid Phosphatase, N-terminal domain [PF16656.7, score=41.7]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=26.3]; Immunoglobulin domain [PF18452.3, score=25.2]} {Human: ENSG00000067141, NEO1, neogenin 1, [RH, Score=313, Expect=1e-86]} {Mouse: ENSMUSG00000032340, Neo1, neogenin, [RH, Score=298, Expect=8e-82]} {Dmel: FBgn0011592, fra, frazzled, [RH, Score=242, Expect=2e-64]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=82.8, Expect=2e-15]} {Smed: dd_Smed_v6_11409_0_1, dd_Smed_v6_11409_0_1, [RH, Score=114, Expect=2e-25]} {RNA1509_18708} {RNA1310_6185.1} {RNA815_22774}

Mlig455_064889 {REF} {Length: 4838} {Pfam: Fibronectin type III domain [PF00041.23, score=167.9]; Immunoglobulin domain [PF13927.8, score=111.8]; Immunoglobulin I-set domain [PF07679.18, score=105.5]; Immunoglobulin domain [PF13895.8, score=85.9]; Immunoglobulin domain [PF00047.27, score=60.6]; Immunoglobulin V-set domain [PF07686.19, score=50.4]; Purple acid Phosphatase, N-terminal domain [PF16656.7, score=42.6]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=26.5]; Immunoglobulin domain [PF18452.3, score=25.3]; Neuron-derived neurotrophic factor [PF10179.11, score=20.3]} {Human: ENSG00000067141, NEO1, neogenin 1, [RH, Score=311, Expect=5e-86]} {Mouse: ENSMUSG00000032340, Neo1, neogenin, [RH, Score=300, Expect=2e-82]} {Dmel: FBgn0011592, fra, frazzled, [RH, Score=239, Expect=1e-63]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=81.6, Expect=4e-15]} {Smed: dd_Smed_v6_7195_0_1, dd_Smed_v6_7195_0_1, [Score=111, Expect=2e-24]} {RNA1509_18708} {RNA1310_6185.1} {RNA815_22774}
11. MligTC455_15500 74 1.54 Mlig455_044618

Neo: -

Age: -

GABBR2 1.683 - - - 0.958 - 0.725 Mlig455_044618 {REF} {Length: 2484} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=138.4]; Receptor family ligand binding region [PF01094.30, score=57.8]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=184, Expect=2e-48]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=182, Expect=8e-48]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=173, Expect=9e-45]} {Celegans: WBGene00022675, gbb-2, GABA B receptor subunit; GABAB2 receptor subunit, [Score=165, Expect=1e-42]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=122, Expect=4e-31]} {RNA1310_32095} {RNA815_22947}
12. MligTC455_04421 629 13.1 Mlig455_008660, Mlig455_008671

Neo: -

Age: -

Region-enriched R8: 2.627/0.01190
Region-enriched R7: 2.553/0.00144
Region-enriched R3: 2.011/0.01226

0.974 - - - 0.974 - -

Mlig455_008660 {REF} {Length: 2329} {Pfam: Major Facilitator Superfamily [PF07690.18, score=85.4]; MFS/sugar transport protein [PF13347.8, score=44.4]; MFS_1 like family [PF12832.9, score=35.8]; PUCC protein [PF03209.17, score=34.8]} {Smed: dd_Smed_v6_8550_0_1, dd_Smed_v6_8550_0_1, [RH, Score=471, Expect=4e-162]} {RNA1509_18256} {RNA1310_12968} {RNA815_5192}

Mlig455_008671 {REF} {Length: 2325} {Pfam: Major Facilitator Superfamily [PF07690.18, score=83.3]; MFS/sugar transport protein [PF13347.8, score=44.8]; MFS_1 like family [PF12832.9, score=35.3]; PUCC protein [PF03209.17, score=34.7]} {Smed: dd_Smed_v6_8550_0_1, dd_Smed_v6_8550_0_1, [RH, Score=468, Expect=1e-160]} {RNA1509_18256} {RNA1310_12968, RNA1509_18256} {RNA1509_18256, RNA815_5192}
13. MligTC455_18857 62 1.28 Mlig455_061927

Neo: -

Age: Up-Down-Up

0.961 - - - 0.961 - - Mlig455_061927 {REF} {Length: 6008} {RNA1509_41127} {RNA1310_30860} {RNA815_18104}
14. MligTC455_50124 3076 64.07 Mlig455_060177, Mlig455_067095

Neo: -

Age: -

Region-enriched R8: 1.168/0.01387

Regeneration-downregulated BL: -2.273

Regeneration-depleted BL: -2.273

CALM3 0.953 - - - 0.953 - -

Mlig455_060177 {REF} {Length: 1071} {Pfam: EF hand [PF00036.34, score=107.6]; EF-hand domain [PF13405.8, score=91.6]; EF-hand domain pair [PF13499.8, score=90.3]; EF hand [PF13202.8, score=82.3]; EF-hand domain pair [PF13833.8, score=73.8]; EF-hand domain [PF14658.8, score=33.5]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=27.0]} {Human: ENSG00000160014, CALM3, calmodulin 3, [Score=122, Expect=3e-35]; ENSG00000198668, CALM1, calmodulin 1, [Score=122, Expect=3e-35]; ENSG00000178363, CALML3, calmodulin like 3, [Score=122, Expect=2e-35]; ENSG00000143933, CALM2, calmodulin 2, [Score=122, Expect=3e-35]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=122, Expect=2e-35]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=122, Expect=2e-35]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=122, Expect=2e-35]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=120, Expect=9e-35]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=124, Expect=4e-36]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=124, Expect=3e-36]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=124, Expect=3e-36]} {RNA1509_23148, RNA1509_35769} {RNA1310_33050, RNA1509_23148, RNA1509_35769} {RNA1509_23148, RNA1509_35769, RNA815_15287}

Mlig455_067095 {REF} {Length: 1046} {Pfam: EF hand [PF00036.34, score=107.6]; EF-hand domain [PF13405.8, score=91.6]; EF-hand domain pair [PF13499.8, score=90.3]; EF hand [PF13202.8, score=82.3]; EF-hand domain pair [PF13833.8, score=73.8]; EF-hand domain [PF14658.8, score=33.5]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=27.0]} {Human: ENSG00000160014, CALM3, calmodulin 3, [Score=122, Expect=3e-35]; ENSG00000198668, CALM1, calmodulin 1, [Score=122, Expect=3e-35]; ENSG00000178363, CALML3, calmodulin like 3, [Score=122, Expect=2e-35]; ENSG00000143933, CALM2, calmodulin 2, [Score=122, Expect=3e-35]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=122, Expect=2e-35]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=122, Expect=2e-35]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=122, Expect=2e-35]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=120, Expect=9e-35]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=124, Expect=4e-36]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=124, Expect=3e-36]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=124, Expect=3e-36]} {RNA1509_23148, RNA1509_26519} {RNA1310_33050, RNA1509_26519} {RNA1509_26519, RNA815_15287}
15. MligTC455_19664 141 2.94 Mlig455_056614

Neo: -

Age: -

Region-enriched R2: 5.722/0.03687
Region-enriched R6: 4.975/0.01610

0.95 - - - 0.950 - - Mlig455_056614 {REF} {Length: 1585} {Pfam: Lectin C-type domain [PF00059.23, score=68.8]} {Mouse: ENSMUSG00000014542, Clec4f, C-type lectin domain family 4, member f, [Score=53.9, Expect=3e-08]} {Dmel: FBgn0035199, tfc, triforce, [RH, Score=64.3, Expect=1e-12]} {Celegans: WBGene00022858, ZK1193.2, [Score=57.4, Expect=2e-09]} {RNA1310_27721} {RNA815_13332}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA